Home > Healthcare > Pharmaceuticals > Drug Delivery > Transdermal Drug Delivery Systems Market

Transdermal Drug Delivery Systems Market Share

Report ID: GMI5548
Published Date: Apr 2023
Report Format: PDF

Download Free Sample

Transdermal Drug Delivery System Market Share

Key players in the transdermal drug delivery system market are:

Novartis
Mylan
Amneal Pharmaceuticals Inc
Zydus Pharmaceuticals, Inc
UCB
Hisamitsu Pharmaceutical Co Inc
Corium Inc
Micropoint Technologies
Sparsha Pharma International Pvt. Ltd.,
Luye Pharma.

Companies operating in this business vertical are indulging strategic associations and drug R&D projects to strengthen their market standing.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for transdermal drug delivery system was worth more than USD 29 billion in 2022 and is poised to exhibit over 8% CAGR during 2023-2032, owing to the mounting burden of chronic health disorders.

Transdermal patches segment is speculated to be worth over USD 35.5 billion by 2032, given the consistent technological developments in existing drug delivery systems.

Pain management segment is estimated to reach over USD 19.5 billion by 2032, driven by the rapid surge in the incidences of cancer worldwide.

Major companies in the transdermal drug delivery system market are Novartis, Mylan, Amneal Pharmaceuticals, Inc., Zydus Pharmaceuticals, Inc., UCB, Hisamitsu Pharmaceutical Co., Inc., Corium, Inc., Micropoint Technologies, Sparsha Pharma International Pvt. Ltd., and Luye Pharma.